516 results
MOCA I study: microvascular obstruction measured using dMVR
23 Jul 2020
STEMI patients treated with primary PCI have a high risk of cardiovascular events. However, the diagnosis of Microvascular obstruction (MVO) in cathlabs immediately after PCI remains difficult due to the lack of validated algorithm.
Author
Multivessel versus culprit-only revascularisation in STEMI and multivessel coronary artery disease: meta-analysis of randomised trials
23 Jul 2020
The current meta-analysis study sought to evaluate contemporary randomized trials on multivessel versus IRA-only PCI in patients presenting with STEMI and multivessel CAD.
Reviewer
PCR e-Course Hot lines: drugs and devices for STEMI management
Watch this session to know more about ultrathin-strut vs thin-strut DES in patients with STEMI undergoing percutaneous coronary intervention (BIOSTEMI), RCT between bioresorbable and durable polymer stent by serial OCT assessment (MECHANISM-AMI), and the results of the FUNCOMBO trial.
Subcutaneous selatogrel inhibits platelet aggregation in patients with acute myocardial infarction
07 Jul 2020
This study sought to assess the antiplatelet response to selatogrel, a novel subcutaneous reversible P2Y12 receptor antagonist, in patients with AMI.
Reviewer
Reviewer
FABOLUS FASTER Trial Review: Cangrelor, Tirofiban and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment Elevation Myocardial Infarction
03 Jul 2020
The investigator sought to determine the acute pharmacodynamic effects of cangrelor, tirofiban or prasugrel, as integral or chewed tablets, in STEMI patients undergoing primary PCI.
Author
Emerging from the SARS-COV-2 crisis: using immersive team simulation to optimise safety and outcomes
03 Jul 2020 – From PCR e-Course 2020
In this video, Rasha Al-Lamee, UK; Iqbal Malik, UK and David Sparv, Sweden, share information on how you can integrate simulation in your own cathlab to maintain quality and safety without training on real people.
Related content: Access a collection of valuable resources on how to protect...
Randomised comparison of the polymer-free biolimus-coated BioFreedom stent with the ultrathin strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with PCI: the SORT OUT IX Trial
03 Jul 2020
While investigations testing differences in efficacy and safety between drug-eluting stents according to the characteristics of the coating – durable, bioresorbable, or polymer-free – have shown mixed results, several studies have highlighted the benefit of implanting a device with thinner strut.
Reviewer
Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome : the TICO randomised clinical trial
02 Jul 2020
The outstanding results of the TICO trial have to be interpreted in light of a number of considerations and the generalisability of its results in other contexts requires further analysis.
Reviewer
PCR e-Course Hot Lines in STEMI interventions: First-in-Man and novel pharmacological strategies
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines in STEMI interventions presented during PCR e-Course 2020, followed by an analysis of these results and their impact on your practice: MOCA I Study, ON-TIME 3 trial, FABOLUS FASTER.
Physiology or intracoronary imaging; or both? or none? - part 2
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SOCT-PCI Study, impact of PPG index on PCI, angiography-derived IMR.
